This study utilized U.S. death certificate data from 1973 to 2012 to categorize cancer patient deaths into three categories: index-cancer, nonindex-cancer, and non-cancer causes. The research found that the proportion of deaths due to index cancer decreased significantly over time, from over 60% to less than 30% in certain cancers.
This review article discusses the role of MTHFR mutations, particularly the C677T and A1298C polymorphisms, in elevating homocysteine levels, which are associated with an increased risk of cardiovascular diseases such as stroke and heart attack. The review highlights that while MTHFR mutations alone do not directly cause cardiovascular disease, they
This study analyzed the relationship between the MTHFR gene polymorphism (C677T) and cardiovascular risks in a Chinese population with low folate intake. It found that individuals with the TT genotype had a significantly higher risk of stroke and heart disease compared to those with the CC genotype. The findings suggest
The article reviews the use of chelation therapy for treating cardiovascular disease, particularly in patients with diabetes, suggesting that it may reduce cardiovascular events such as heart attacks and strokes by 18-30%. The therapy involves the administration of EDTA, which removes metal ions and calcium from the bloodstream, potentially improving
Chelation therapy is an alternative treatment that uses agents like EDTA to bind and remove heavy metals and other toxins from the body, often employed to treat conditions such as heavy metal poisoning and cardiovascular disease. The article explains that this therapy can improve circulation, help detoxify the body, and
This article reviews the potential benefits of edetate disodium (a chelating agent) in post-myocardial infarction (MI) patients, particularly those with diabetes, for secondary prevention. The Trial to Assess Chelation Therapy (TACT) demonstrated that edetate disodium therapy led to significant cardiovascular improvements, especially in diabetic patients, showing comparable or superior benefits
The study “Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial Infarction: The TACT Randomized Trial” evaluated whether EDTA chelation therapy could reduce cardiovascular events in patients with a history of myocardial infarction. In this double-blind, placebo-controlled trial involving 1708 participants, the primary endpoint was
The study evaluated the efficacy of evacetrapib, a CETP inhibitor, in reducing major adverse cardiovascular events (MACE) despite its ability to significantly raise HDL cholesterol by 130% and lower LDL cholesterol by 37%. Conducted on over 12,000 high-risk cardiovascular patients, the trial was halted early due to a lack of
This article highlights the benefits and safety of hormone replacement therapy (HRT) for women, particularly those starting before the age of 60. It reviews how HRT alleviates symptoms of estrogen deficiency such as hot flashes, vaginal dryness, and osteoporotic fractures, with transdermal estradiol being preferred for its safety. HRT also
The article “Testosterone and Cardiovascular Health” is a literature review that examines the relationship between testosterone therapy and cardiovascular health, focusing on conflicting evidence regarding the cardiovascular risks and benefits of testosterone supplementation. It addresses the ongoing debate about testosterone’s potential to cause cardiovascular events, with some studies suggesting increased
